Product Details
| Product Name: Temozolomide | CAS No.: 85622-93-1 |
| Min. Order: 1kg | Purity: 99.0 |
| Supply Ability: 100kg | Release date: 2025/10/31 |
Temozolomide is the first effective orally-taken imidazole and tetrazine-class anticancer drug which belongs to the second generation of an alkylating agent with antitumor activity without liver metabolic activation after oral administration. It is characterized by easily penetration through the blood-brain barrier, good tolerance and being not superimposed with other drugs toxicity, and having synergistic effect with radiotherapy which is suitable for treating malignant glioma recurrence after conventional treatment such as glioblastoma multiforme tumors or degenerative astrocytoma. It is first-line drug for treatment of metastatic melanoma.
Company Profile Introduction
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $42.00/10mg |
VIP4Y
|
TargetMol Chemicals Inc.
|
2025-11-04 | |
| $42.00/10mg |
VIP6Y
|
TargetMol Chemicals Inc.
|
2025-11-04 | |
| $0.00/1kg |
VIP1Y
|
Beijing Ruqueen Biotech., Co., Ltd.
|
2025-07-23 | |
| $/ |
VIP5Y
|
RongNa Biotechnology Co.,Ltd
|
2025-04-29 | |
| $0.00/25kg |
VIP2Y
|
Shaanxi Dideu New Materials Co. Ltd
|
2025-03-01 | |
| $10.00/1KG |
VIP7Y
|
Hebei Chuanghai Biotechnology Co., Ltd
|
2024-12-03 | |
| $0.00/1g |
VIP2Y
|
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
|
2024-08-09 | |
| $40.00/10mg |
VIP3Y
|
Zibo Hangyu Biotechnology Development Co., Ltd
|
2024-07-10 | |
| $5.00/25kg |
Ouhuang Engineering Materials (Hubei) Co., Ltd
|
2024-04-28 | ||
| $32.00/1KG |
VIP2Y
|
Henan Fengda Chemical Co., Ltd
|
2024-04-15 |

China